Filter Results:
(353)
Show Results For
- All HBS Web
(353)
- People (2)
- News (142)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (70)
Show Results For
- All HBS Web
(353)
- People (2)
- News (142)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (70)
- 01 Sep 2012
- News
High Honors
companies, primarily in the computer and health-care realm. In the four decades since, Johnson has helped build the biotech industry and earned a reputation as a thoughtful investor, trusted adviser, and generous philanthropist. Among his... View Details
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
case:https://hbsp.harvard.edu/product/318082-PDF-ENG Harvard Business School Case 318-083 Sandra Brown Goes Digital (B): The Commitment Decision Sandra Brown, a middle manager at a biotech company who has led internal and external... View Details
Keywords: Dina Gerdeman
- 01 Dec 2004
- News
The Future of Stem Cells
year for research on existing lines, even as other countries are investing many times that amount. Says Cynthia Fisher (MBA ’90), president and CEO of BioMed 20/20 Technologies, a biotech and medical information products firm, “The... View Details
Keywords: Garry Emmons
- 28 Aug 2012
- First Look
First Look: August 28
determining a new venture's future alliance formation diminishes as the new venture's prominence in alliance networks increases. Evidence from biotech alliances between new ventures and established companies provides support for our... View Details
Keywords: Sean Silverthorne
- Web
Year in Review | Annual Report 2024
closely with leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of entrepreneurs shaping the future of science. To date, the Blavatnik Fellows have created 35 companies... View Details
- 25 Feb 2014
- First Look
First Look: February 25
recent firm performance? Purchase this case: http://hbr.org/product/say-on-pay-qualcomm-inc-shareholders-vote-maybe-in-2012/an/114005-PDF-ENG Harvard Business School Case 213-047 Aqua Bounty Valuation of a pre-revenue biotech company at... View Details
Keywords: Sean Silverthorne
- 12 Sep 2006
- First Look
First Look: September 12, 2006
organization's relational capacity. The benefits will reverberate throughout every dimension of the company's work. Financial Contracting in Biotech Strategic Alliances Authors:David T. Robinson and Toby E. Stuart Periodical:Journal of... View Details
Keywords: Sean Silverthorne
- 01 Sep 2008
- News
Mara Aspinall
ASPINALL Illustration by Jack Unruh When you ask people about their great fears in life, virtually everyone talks about cancer,” says Mara G. Aspinall (MBA ’87), past president of Genzyme Genetics, a Westborough, Massachusetts-based division of the View Details
- 29 Oct 2000
- Research & Ideas
The Entrepreneurial Venture: A Conversation
decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging company and a VC-backed View Details
Keywords: by Susan Young
- 05 Aug 2016
- News
Accelerating Change on Medicine’s Final Frontier
program had two origins: Princeton engineering lecturer James Shinn (MBA 1981) and biotech entrepreneur Gregory Stock (MBA 1987), the brother of one of Amadio’s biology professors. “They impressed upon me how interesting it would be to... View Details
Keywords: Robert S. Benchley
- 07 Oct 2014
- First Look
First Look: October 7
(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for... View Details
Keywords: Sean Silverthorne
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Download the paper: http://www.hbs.edu/research/pdf/09-099.pdf Cases & Course MaterialsAvid Radiopharmaceuticals: The Venture Debt Question Harvard Business School Case 809-086 The CEO of a promising biotech company must decide how... View Details
Keywords: Martha Lagace
- Web
Global Activities 2020-2021 - Global Activities 2021
Harvard Medical School through the Harvard Department of Stem Cell and Regenerative Biology—to explore biotech careers in emerging markets, particularly in the Middle East and North Africa region. Her family’s difficulty obtaining health... View Details
- 01 Sep 2014
- News
All For One
don’t know what the answer is. They have to act, not plan their way forward. Hill began to despair of finding an answer to her problem until a chance meeting with Pixar executive Greg Brandeau in the lobby of a biotech firm—Hill was there... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
four-and-a-half year period. Problems involved everything from biotech to consumer products and agrochemicals. Thanks to broadcasting, nearly one-third of the previously unsolved problems found successful solutions. "Innovations... View Details
Keywords: by Martha Lagace
- 01 Sep 2008
- News
Balanced Equation
significantly. However, we remain a service organization helping entrepreneurs with disruptive technologies that create or transform business. KPCB has always focused on biotech and information technologies. Today we’ve added energy... View Details
- 01 Jun 2007
- News
Mission Possible
“Rudy contends that if we can identify the other ten or twelve genes that are players, we can give the biotech industry so many more shots to come up with a therapy,” explains McCance, who, along with his cofounders, is privately... View Details
- 21 Apr 2009
- First Look
First Look: April 21, 2009
this case: http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807106 Note on Biotech Business Development Harvard Business School Note 807-032 Describes the business development process in biotechnology... View Details
Keywords: Martha Lagace
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
deals with Bed Bath & Beyond, Frontier Airlines, and Johnson & Johnson. “You’re always asking, is this the right business model? But there are no answers. The market and technology are constantly changing,” Riesenfeld remarks. The biotech... View Details